Drugs / Lyophilized Human Rabies Vaccine (Human Diploid Cell)
Lyophilized Human Rabies Vaccine (Human Diploid Cell)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07338786 | Sep 2025 → Jan 2026 overdue | rabies | Changchun BCHT Biotechnology Co. | Enrolling by invitation | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lyophilized Human Rabies Vaccine (Human Diploid Cell) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07338786 ↗ |
| Modality | Vaccine | “Lyophilized Human Rabies Vaccine (Human Diploid Cell)” NCT07338786 ↗ |